The global Albendazole market size is predicted to grow from US$ 181 million in 2025 to US$ 288 million in 2031; it is expected to grow at a CAGR of 8.1% from 2025 to 2031.
Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite"s absorption of glucose, leading to depletion of the body"s glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.
This is a relatively concentrated market, mainly due to the particularity of the pharmaceutical industry, where there are higher operating licenses and barriers, technical barriers, capital barriers and environmental barriers, so the concentration is higher. From the perspective of the global market, the original research firm GSK"s albendazole accounts for more than 40% of the entire industry and is the leading enterprise in the albendazole industry. From the perspective of the Chinese market, the market concentration is also relatively high. The main companies are Huazhong Pharmaceutical and Jiangsu Qihui, which together account for 70% of the domestic market.
The 鈥淎lbendazole Industry Forecast鈥� looks at past sales and reviews total world Albendazole sales in 2024, providing a comprehensive analysis by region and market sector of projected Albendazole sales for 2025 through 2031. With Albendazole sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Albendazole industry.
This Insight Report provides a comprehensive analysis of the global Albendazole landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Albendazole portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Albendazole market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Albendazole and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Albendazole.
This report presents a comprehensive overview, market shares, and growth opportunities of Albendazole market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Tablet
Capsule
Other
Segmentation by Application:
Human
Veterinary
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GlaxoSmithKline
Huazhong Pharmaceutical
Jiangsu Qihui
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Zhongjia Pharmaceutical
Fredun Pharmaceuticals Ltd
Supharma Chem
Salius Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Albendazole market?
What factors are driving Albendazole market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Albendazole market opportunities vary by end market size?
How does Albendazole break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Albendazole Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Albendazole by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Albendazole by Country/Region, 2020, 2024 & 2031
2.2 Albendazole Segment by Type
2.2.1 Tablet
2.2.2 Capsule
2.2.3 Other
2.3 Albendazole Sales by Type
2.3.1 Global Albendazole Sales Market Share by Type (2020-2025)
2.3.2 Global Albendazole Revenue and Market Share by Type (2020-2025)
2.3.3 Global Albendazole Sale Price by Type (2020-2025)
2.4 Albendazole Segment by Application
2.4.1 Human
2.4.2 Veterinary
2.5 Albendazole Sales by Application
2.5.1 Global Albendazole Sale Market Share by Application (2020-2025)
2.5.2 Global Albendazole Revenue and Market Share by Application (2020-2025)
2.5.3 Global Albendazole Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Albendazole Breakdown Data by Company
3.1.1 Global Albendazole Annual Sales by Company (2020-2025)
3.1.2 Global Albendazole Sales Market Share by Company (2020-2025)
3.2 Global Albendazole Annual Revenue by Company (2020-2025)
3.2.1 Global Albendazole Revenue by Company (2020-2025)
3.2.2 Global Albendazole Revenue Market Share by Company (2020-2025)
3.3 Global Albendazole Sale Price by Company
3.4 Key Manufacturers Albendazole Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Albendazole Product Location Distribution
3.4.2 Players Albendazole Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Albendazole by Geographic Region
4.1 World Historic Albendazole Market Size by Geographic Region (2020-2025)
4.1.1 Global Albendazole Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Albendazole Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Albendazole Market Size by Country/Region (2020-2025)
4.2.1 Global Albendazole Annual Sales by Country/Region (2020-2025)
4.2.2 Global Albendazole Annual Revenue by Country/Region (2020-2025)
4.3 Americas Albendazole Sales Growth
4.4 APAC Albendazole Sales Growth
4.5 Europe Albendazole Sales Growth
4.6 Middle East & Africa Albendazole Sales Growth
5 Americas
5.1 Americas Albendazole Sales by Country
5.1.1 Americas Albendazole Sales by Country (2020-2025)
5.1.2 Americas Albendazole Revenue by Country (2020-2025)
5.2 Americas Albendazole Sales by Type (2020-2025)
5.3 Americas Albendazole Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Albendazole Sales by Region
6.1.1 APAC Albendazole Sales by Region (2020-2025)
6.1.2 APAC Albendazole Revenue by Region (2020-2025)
6.2 APAC Albendazole Sales by Type (2020-2025)
6.3 APAC Albendazole Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Albendazole by Country
7.1.1 Europe Albendazole Sales by Country (2020-2025)
7.1.2 Europe Albendazole Revenue by Country (2020-2025)
7.2 Europe Albendazole Sales by Type (2020-2025)
7.3 Europe Albendazole Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Albendazole by Country
8.1.1 Middle East & Africa Albendazole Sales by Country (2020-2025)
8.1.2 Middle East & Africa Albendazole Revenue by Country (2020-2025)
8.2 Middle East & Africa Albendazole Sales by Type (2020-2025)
8.3 Middle East & Africa Albendazole Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Albendazole
10.3 Manufacturing Process Analysis of Albendazole
10.4 Industry Chain Structure of Albendazole
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Albendazole Distributors
11.3 Albendazole Customer
12 World Forecast Review for Albendazole by Geographic Region
12.1 Global Albendazole Market Size Forecast by Region
12.1.1 Global Albendazole Forecast by Region (2026-2031)
12.1.2 Global Albendazole Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Albendazole Forecast by Type (2026-2031)
12.7 Global Albendazole Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Albendazole Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Albendazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Huazhong Pharmaceutical
13.2.1 Huazhong Pharmaceutical Company Information
13.2.2 Huazhong Pharmaceutical Albendazole Product Portfolios and Specifications
13.2.3 Huazhong Pharmaceutical Albendazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Huazhong Pharmaceutical Main Business Overview
13.2.5 Huazhong Pharmaceutical Latest Developments
13.3 Jiangsu Qihui
13.3.1 Jiangsu Qihui Company Information
13.3.2 Jiangsu Qihui Albendazole Product Portfolios and Specifications
13.3.3 Jiangsu Qihui Albendazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Jiangsu Qihui Main Business Overview
13.3.5 Jiangsu Qihui Latest Developments
13.4 Sequent Scientific
13.4.1 Sequent Scientific Company Information
13.4.2 Sequent Scientific Albendazole Product Portfolios and Specifications
13.4.3 Sequent Scientific Albendazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sequent Scientific Main Business Overview
13.4.5 Sequent Scientific Latest Developments
13.5 K.A. Malle Pharmaceuticals
13.5.1 K.A. Malle Pharmaceuticals Company Information
13.5.2 K.A. Malle Pharmaceuticals Albendazole Product Portfolios and Specifications
13.5.3 K.A. Malle Pharmaceuticals Albendazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 K.A. Malle Pharmaceuticals Main Business Overview
13.5.5 K.A. Malle Pharmaceuticals Latest Developments
13.6 Lasa Supergenerics Limited
13.6.1 Lasa Supergenerics Limited Company Information
13.6.2 Lasa Supergenerics Limited Albendazole Product Portfolios and Specifications
13.6.3 Lasa Supergenerics Limited Albendazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Lasa Supergenerics Limited Main Business Overview
13.6.5 Lasa Supergenerics Limited Latest Developments
13.7 Zhongjia Pharmaceutical
13.7.1 Zhongjia Pharmaceutical Company Information
13.7.2 Zhongjia Pharmaceutical Albendazole Product Portfolios and Specifications
13.7.3 Zhongjia Pharmaceutical Albendazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Zhongjia Pharmaceutical Main Business Overview
13.7.5 Zhongjia Pharmaceutical Latest Developments
13.8 Fredun Pharmaceuticals Ltd
13.8.1 Fredun Pharmaceuticals Ltd Company Information
13.8.2 Fredun Pharmaceuticals Ltd Albendazole Product Portfolios and Specifications
13.8.3 Fredun Pharmaceuticals Ltd Albendazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Fredun Pharmaceuticals Ltd Main Business Overview
13.8.5 Fredun Pharmaceuticals Ltd Latest Developments
13.9 Supharma Chem
13.9.1 Supharma Chem Company Information
13.9.2 Supharma Chem Albendazole Product Portfolios and Specifications
13.9.3 Supharma Chem Albendazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Supharma Chem Main Business Overview
13.9.5 Supharma Chem Latest Developments
13.10 Salius Pharma
13.10.1 Salius Pharma Company Information
13.10.2 Salius Pharma Albendazole Product Portfolios and Specifications
13.10.3 Salius Pharma Albendazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Salius Pharma Main Business Overview
13.10.5 Salius Pharma Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
